GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (BOM:531349) » Definitions » Total Inventories

Panacea Biotec (BOM:531349) Total Inventories : ₹1,779 Mil (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Panacea Biotec Total Inventories?

Panacea Biotec's total inventories for the quarter that ended in Mar. 2024 was ₹1,779 Mil. Panacea Biotec's average total inventories from the quarter that ended in Dec. 2023 to the quarter that ended in Mar. 2024 was ₹890 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Panacea Biotec's Net-Net Working Capital per share for the quarter that ended in Mar. 2024 was ₹-13.32.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Panacea Biotec's Days Inventory for the three months ended in Mar. 2024 was 163.19.

Inventory Turnover measures how fast the company turns over its inventory within a year. Panacea Biotec's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.56.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Panacea Biotec's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.65.


Panacea Biotec Total Inventories Historical Data

The historical data trend for Panacea Biotec's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacea Biotec Total Inventories Chart

Panacea Biotec Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,476.91 1,741.37 2,127.23 2,020.93 1,779.40

Panacea Biotec Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,020.93 - 1,999.20 - 1,779.40

Panacea Biotec Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Panacea Biotec  (BOM:531349) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Panacea Biotec's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2024 is

Net-Net Working Capital Per Share (Q: Mar. 2024 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1850.1+0.75 * 574.2+0.5 * 1779.4-4024.5
-0--38.2)/61.2508
=-13.32

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Panacea Biotec's Days Inventory for the three months ended in Mar. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Mar. 2024 )/Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=889.7/497.5*365 / 4
=163.19

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Panacea Biotec's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Mar. 2024 ) / Average Total Inventories (Q: Mar. 2024 )
=497.5 / 889.7
=0.56

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Panacea Biotec's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=889.7 / 1364.6
=0.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Panacea Biotec Total Inventories Related Terms

Thank you for viewing the detailed overview of Panacea Biotec's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Panacea Biotec (BOM:531349) Business Description

Traded in Other Exchanges
Address
Mathura Road, B-1 Extn./G-3, Mohan Co-operative Industrial Estate, New Delhi, IND, 110 044
Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.

Panacea Biotec (BOM:531349) Headlines

No Headlines